← Back to Clinical Trials
Recruiting NCT07020910

NCT07020910 Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07020910
Status Recruiting
Phase
Sponsor Zentralklinik Bad Berka
Condition Cardiac Arrhythmias
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2024-08-01
Primary Completion 2029-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,000 participants in total. It began in 2024-08-01 with a primary completion date of 2029-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Bad Berka Heart Rhythm Registry (2B2R) is a prospective, single-center observational cohort designed to systematically collect and analyze data of patients undergoing cardiac arrhythmia therapy as well as implantation of cardiac electronic devices (CIEDs) at the Heart Center Bad Berka. The register aims to evaluate procedural safety, acute and long-term efficacy, and clinical outcomes across a broad spectrum of arrhythmias and interventional strategies, including novel technologies such as pulsed field ablation (PFA) and conduction system pacing. The registry is intended to generate real-world evidence to support clinical decision-making, identify predictors of outcomes, and contribute to quality assurance and innovation in the field of cardiac electrophysiology.

Eligibility Criteria

Inclusion Criteria: * Age ≥18 years * At risk of or with documented cardiac arrhythmia undergoing medical or interventional therapy at the Heart Center Bad Berka * Informed consent obtained Exclusion Criteria: * Inability or unwillingness to provide informed consent * Participation in another interventional trial that precludes registry inclusion

Contact & Investigator

Central Contact

Christoph Geller, Prof. Dr. med.

✉ kar@zentralklinik.de

📞 +49 (0) 36458 5-1201 / 1205

Frequently Asked Questions

Who can join the NCT07020910 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrhythmias. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07020910 currently recruiting?

Yes, NCT07020910 is actively recruiting participants. Contact the research team at kar@zentralklinik.de for enrollment information.

Where is the NCT07020910 trial being conducted?

This trial is being conducted at Bad Berka, Germany.

Who is sponsoring the NCT07020910 clinical trial?

NCT07020910 is sponsored by Zentralklinik Bad Berka. The trial plans to enroll 5,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology